Description
This CME course by ScientiaCME is mainly designed for Hematologists to provide in-depth knowledge about Hematology/Oncology. ScientiaCME is accredited by ACCME with the main motive to provide up-to-date information and to enhance the skills of practitioners so that they can incorporate the recent developments into their daily practice. ScientiaCME Hematology/Oncology is available online. Establish user name and password to gain access to 8 lectures for Mds-- Acute Lymphoblastic Leukemia (ALL): Highlights from the ASH 2016: Take-Aways, Emerging Practice Changes, and Barriers to their Implementation (0.5 hr CME)
- Acute Lymphoblastic Leukemia (ALL): Highlights from the 2016 American Society for Clinical Oncology: Take-Aways, Emerging Practice Changes, and Barriers to their Implementation (0.75 hr CE)
- Advancing Treatment Strategies in Acute Lymphoblastic Leukemia (ALL) Drug Therapy
- Multiple Myeloma Pharmacotherapy: Therapeutic Updates, Best Practices, and Emerging Treatment Options (1 hr CE)
- Acute Lymphoblastic Leukemia (ALL): Highlights from the ASH 2015: Take-Aways, Emerging Practice Changes, and Barriers to their Implementation (1 hr CME)
- The Newest in Non-Small Cell Lung Cancer (NSCLC): Emerging Therapies, Novel Approaches, Therapeutic Updates, and Barriers to Care and Incorporating Best Practice (1 hr CME)
- Renal cell carcinoma (RCC): Highlights from the 2015 American Society of Clinical Oncology: Take-Aways, Emerging Practice Changes, and Barriers to their Implementation(1 hr CME)
- Acute Lymphoblastic Leukemia in Adults(1 hr CME)
